News & Perspective

Feb 11, 2011

Feb 11, 2011

Study showing high effectiveness for H1N1 vaccine stirs debate

(CIDRAP News) – A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.

Sep 24, 2009

Sep 24, 2009

Businesses share lessons from spring H1N1 outbreak

(CIDRAP News) – On the final day of a business preparedness summit in Minneapolis, a panel of experts emphasized having clear, open communication with employees as well as having flexible plans—lessons they learned from being on the frontlines in Mexico and the Southern Hemisphere during the spring novel H1N1 outbreak.

Jun 11, 2009

Jun 11, 2009

WHO declares pandemic of novel H1N1 virus

(CIDRAP News) – After delaying action for weeks as the novel H1N1 influenza virus took hold in far-flung parts of the globe, the World Health Organization (WHO) today declared a full-fledged pandemic, formally recognizing that the virus is becoming a global contagion.

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»